Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma

Victor Jeannot (1) , Benoît Busser (1, 2) , Laetitia Vanwonterghem (1) , Sophie Michallet (1) , Sana Ferroudj (1) , Murat Cokol (3) , Jean-Luc Coll (1) , Mehmet Ozturk (1, 4) , Amandine Hurbin (1)

1 IAB - Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble)
2 CHUGA - Centre Hospitalier Universitaire [CHU Grenoble]
3 Sabanci University [Istanbul]
4 DEÜ - Dokuz Eylül Üniversitesi = Dokuz Eylül University [Izmir]

Domaines: Sciences du Vivant [q-bio]; Cancer

Victor Jeannot, Benoît Busser, Laetitia Vanwonterghem, Sophie Michallet, Sana Ferroudj, et al.. Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma. OncoTargets and Therapy, 2016, 9, pp.6843-6855. ⟨10.2147/OTT.S117743⟩. ⟨hal-02347748⟩